Allogeneic bone marrow transplantation in a 7-year-old girl with congenital erythropoietic porphyria: A treatment dilemma

British Journal of Dermatology

Volumn 156, Issue 3, 2007, Pages 567-571

  Taibjee, S M ^a   Stevenson, O E ^b   Abdullah, A ^c   Tan, C Y ^c   Darbyshire, P ^a   Moss, C ^a   Goodyear, H ^b   Heagerty, A ^b   Whatley, S ^d   Badminton, M N ^d  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Allogeneic; Bone marrow transplantation; Congenital erythropoietic porphyria; Graft versus host disease; G nther's disease; Postinflammatory hypopigmentation

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; ARTICLE; CASE REPORT; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DECISION MAKING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HYPOPIGMENTATION; METABOLIC DISORDER; MORBIDITY; PATIENT COMPLIANCE; PHOTOSENSITIVITY; PRIORITY JOURNAL; SCHOOL CHILD;

BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VS HOST DISEASE; HUMANS; HYPOPIGMENTATION; PORPHYRIA, ERYTHROPOIETIC;

EID: 33846953888     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07699.x     Document Type: Article

References (24)

1. Tezcan I, Xu W, Gurgey M et al. Congenital erythropoietic porphyria successfully treated by allogenic bone marrow transplantation. Blood 1998; 92:4053-8.
2. Desnick RJ, Astrin KH. Congenital erythropoietic porphyria: advances in pathogenesis and treatment. Br J Haematol 2002; 117:779-95.
3. Human Gene Mutation Database. http://www.hgmd.cf.ac.uk/ac/gene.php?gene= UROS (last accessed 26 October 2006).
4. Desnick RJ, Glass IA, Xu W et al. Molecular genetics of congenital erythropoietic porphyria. Semin Liver Dis 1998; 18:77-84.
5. Freesemann AG, Bhutani LK, Jacob K, Doss MO. Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease). Arch Dermatol Res 1997; 289:272-6.
6. Badminton MN, Elder GH. Management of acute and cutaneous porphyrias. Int J Clin Pract 2002; 56:272-8.
7. Guarini L, Piomelli S, Poh-Fitzpatrick MB. Hydroxyurea in congenital erythropoietic porphyria. N Engl J Med 1994; 330:1091-2.
8. Hift RJ, Meissner PN, Kirsch RE. The effect of oral activated charcoal on the course of congenital erythropoietic porphyria. Br J Dermatol 1993; 129:14-17.
9. Pimstone NR, Gandhi SN, Mukerji SK. Therapeutic efficacy of oral activated charcoal in congenital erythropoietic porphyria. N Engl J Med 1987; 316:390-3.
10. Piomelli S, Poh-Fitzpatrick MB, Seaman C et al. Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high level transfusions. N Engl J Med 1986; 314:1029-31.
11. Kauppinen R, Glass IA, Aizencang G et al. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells. Mol Genet Metab 1998; 65:10-17.
12. Mazurier F, Geronomi F, Lamrissi-Garcia I et al. Correction of deficient CD34(+) cells from peripheral blood after mobilisation in a patient with congenital erythropoietic porphyria. Mol Ther 2001; 3:411-17.
13. Kauffmann L, Evans DIK, Stevens RF, Weinkove C. Bone marrow transplantation for congenital erythropoietic porphyria. Lancet 1991; 337:1510-11.
14. Dupuis-Girod S, Akkari V, Ged C et al. Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease). Eur J Pediatr 2005; 164:104-7.
15. Harada FA, Shwayder TA, Desnick RJ, Lim HW. Treatment of severe CEP with bone marrow transplant. J Am Acad Dermatol 2001; 5:279-82.
16. Lagarde C, Hamel-Teillac D, De Prost Y et al. Allogenic bone marrow transplantation in congenital erythropoietic porphyria. Günther's disease. Ann Dermatol Venereol 1998; 125:114-17.
17. Lanino E, Morreale G, Gabarino L et al. Severe congenital erythropoietic porphyria. Complete correction after BMT from an unrelated donor. European Group for Blood and Marrow Transplantation 2001; http://congress.akm. ch/abstract/abstract/abt.ausg_pkt_ses?xssprache=ENGOPT&xnkon_nr= 45&xnSESSION_NR=1612&xnCO_PROFILE=356788# (last accessed 26 October 2006).
18. Shaw PH, Mancini AJ, McConnell JP et al. Treatment of CEP in children by allogenic stem cell transplantation: a case report and review of the literature. Bone Marrow Transplant 2001; 27:101-5.
19. Thomas C, Ged C, Nordmann Y et al. Correction of congenital erythropoietic porphyria by bone marrow transplantation. J Pediatr 1996; 129:453-6.
20. Zix-Kieffer I, Langer B, Eyer D et al. Successful cord blood stem cell transplant for congenital erythropoietic porphyria (Günther's disease). Bone Marrow Transplant 1996; 18:217-20.
21. Dawe SA, Stephens AD, Peters TJ et al. Congenital eythropoietic porphyria: dilemmas in present day management. Clin Exp Dermatol 2002; 27:680-3.
22. Moore MR, McColl KEL, Fitzsimmons EJ et al. The porphyrias. Blood Rev 1990; 4:88-96.
23. De Verneuil H, Ged C, Moreau-Gaudry F. Congenital erythropoietic porphyria. In: The Porphyrin Handbook: Medical Aspects of Porphyrins (Kadish KM, Smith KM, Guilard R, eds), Vol. 14. San Diego: Academic Press, 2003; 43-63.
24. Bolwell BJ. Are predictive factors clinically useful in bone marrow transplantation? Bone Marrow Transplant 2003; 32:853-61.